DK1812581T3 - Fremgangsmåde til fremstilling af optisk aktive N-carbamat-beskyttede beta-lactamer ved optisk oplösning under anvendelse af en candida antarctica lipase - Google Patents

Fremgangsmåde til fremstilling af optisk aktive N-carbamat-beskyttede beta-lactamer ved optisk oplösning under anvendelse af en candida antarctica lipase

Info

Publication number
DK1812581T3
DK1812581T3 DK05826088T DK05826088T DK1812581T3 DK 1812581 T3 DK1812581 T3 DK 1812581T3 DK 05826088 T DK05826088 T DK 05826088T DK 05826088 T DK05826088 T DK 05826088T DK 1812581 T3 DK1812581 T3 DK 1812581T3
Authority
DK
Denmark
Prior art keywords
lactams
carbamate
candida antarctica
preparation
optically active
Prior art date
Application number
DK05826088T
Other languages
Danish (da)
English (en)
Inventor
Ankush Argade
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1812581T3 publication Critical patent/DK1812581T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK05826088T 2004-11-15 2005-11-15 Fremgangsmåde til fremstilling af optisk aktive N-carbamat-beskyttede beta-lactamer ved optisk oplösning under anvendelse af en candida antarctica lipase DK1812581T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62840104P 2004-11-15 2004-11-15
PCT/US2005/041276 WO2006055528A2 (en) 2004-11-15 2005-11-15 Process for the preparation of an optically acitive n-carbamate protected beta-lactam by optical resolution employing a candida antarctica lipase

Publications (1)

Publication Number Publication Date
DK1812581T3 true DK1812581T3 (da) 2009-05-11

Family

ID=36190809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05826088T DK1812581T3 (da) 2004-11-15 2005-11-15 Fremgangsmåde til fremstilling af optisk aktive N-carbamat-beskyttede beta-lactamer ved optisk oplösning under anvendelse af en candida antarctica lipase

Country Status (10)

Country Link
US (1) US7459301B2 (https=)
EP (1) EP1812581B1 (https=)
JP (1) JP4738416B2 (https=)
AT (1) ATE421996T1 (https=)
CA (1) CA2580151C (https=)
DE (1) DE602005012597D1 (https=)
DK (1) DK1812581T3 (https=)
ES (1) ES2320364T3 (https=)
PT (1) PT1812581E (https=)
WO (1) WO2006055528A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754714B2 (en) * 2004-05-18 2010-07-13 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
GB2420559B (en) * 2004-11-15 2008-08-06 Rigel Pharmaceuticals Inc Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
WO2007070872A1 (en) 2005-12-15 2007-06-21 Rigel Pharmaceuticals, Inc. Kinase inhibitors and their uses
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP3076963A4 (en) 2013-12-06 2017-09-13 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd30 antibodies
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
CN111194304B (zh) * 2018-04-18 2022-09-27 宜昌东阳光长江药业股份有限公司 一种桥环化合物的制备方法
US20220305048A1 (en) 2019-08-26 2022-09-29 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE258605T1 (de) 1998-07-09 2004-02-15 Lonza Ag Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten

Also Published As

Publication number Publication date
DE602005012597D1 (de) 2009-03-19
EP1812581A2 (en) 2007-08-01
WO2006055528A3 (en) 2006-08-31
WO2006055528A2 (en) 2006-05-26
JP4738416B2 (ja) 2011-08-03
EP1812581B1 (en) 2009-01-28
CA2580151A1 (en) 2006-05-26
ES2320364T3 (es) 2009-05-21
US7459301B2 (en) 2008-12-02
PT1812581E (pt) 2009-04-22
CA2580151C (en) 2014-02-04
JP2008520206A (ja) 2008-06-19
ATE421996T1 (de) 2009-02-15
US20060166308A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
Busto et al. Hydrolases in the stereoselective synthesis of N-heterocyclic amines and amino acid derivatives
Gotor Biocatalysis applied to the preparation of pharmaceuticals
Margolin Enzymes in the synthesis of chiral drugs
Patel Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances
Milner et al. Biocatalytic approaches to the Henry (nitroaldol) reaction
DK1812581T3 (da) Fremgangsmåde til fremstilling af optisk aktive N-carbamat-beskyttede beta-lactamer ved optisk oplösning under anvendelse af en candida antarctica lipase
Gotor Non-conventional hydrolase chemistry: amide and carbamate bond formation catalyzed by lipases
Miyazawa Enzymatic resolution of amino acids via ester hydrolysis
Maugeri et al. Reductive amination of ketones catalyzed by whole cell biocatalysts containing imine reductases (IREDs)
DE69914458D1 (de) Verfahren zur enzymatischen auflösung von laktamen
Sergeeva et al. Lipase-catalyzed transamidation of non-activated amides in organic solvent
Gill et al. Biocatalytic ammonolysis of (5S)-4, 5-dihydro-1H-pyrrole-1, 5-dicarboxylic acid, 1-(1, 1-dimethylethyl)-5-ethyl ester: Preparation of an intermediate to the dipeptidyl peptidase IV inhibitor Saxagliptin
Assaf et al. Scope, limitations and classification of lactamases
DK0649907T3 (da) Enzymatisk hydroxyleringsproces til fremstilling af HMG-CoA-reduktaseinhibitorer og mellemprodukter derfor
ATE484575T1 (de) Mikroorganismus des genus corynebacterium der eine erhöhte l-lysinproduktivität hat und verfahren zur herstellung von l-lysin durch besagten mikroorganismus
NO20071602L (no) Fremgangsmate for fremstilling av mycofenolatmofetil ved enzymatisk transsesterifisering
Matsuda et al. A new cyclase family catalyzing head-to-tail macrolactamization of non-ribosomal peptides
Liu et al. Synthesis of methyl (R)-3-(4-fluorophenyl) glutarate via enzymatic desymmetrization of a prochiral diester
DK0904348T3 (da) Fremgangsmåde til fremstilling af aminoalkoholer og derivater deraf
ATE134610T1 (de) Verfahren zur herstellung von optisch aktiven 4- amino-3-hydroxycarbonsäuren
DK0602740T3 (da) Fremgangsmåde til enzymatisk fremstilling af optisk aktive transglycidsyreestere
Lundell et al. Enantiomers of adrenaline-type amino alcohols by Burkholderia cepacia lipase-catalyzed asymmetric acylation
WO2005085462A1 (en) Enzymatic preparation of an enantiomerically enriched beta-2-amino acids
Takabe et al. Convenient route to both enantiomers of chiral 5-hydroxypyrrolidin-2-one and 5-hydroxy-1, 5-dihydropyrrol-2-one: reverse enantioselectivity in lipase-catalyzed kinetic resolution
Martelli et al. Chiral β-lactam-based integrin ligands through Lipase-catalysed kinetic resolution and their enantioselective receptor response